Immunovia AB (STO:IMMNOV), a manufacturer of health care devices, reported on Monday a change in the share capital and number of shares in the company due to share warrants being exercised in the company.
As a result of this, the share capital has increased by SEK6,175.00 to SEK982,742.65, while the number of shares and votes has increased by 123,500 to 19,654,853 shares and votes. Reportedly, the dilution amounts to 0.6%.
According to the company, the share warrants that have been exercised are in part constituted of Immunovia's incentive programme for senior management according to decisions taken at the 2016 AGM, issued the same year.
(EUR1.00=SEK10.75)
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon